LianBio completes merger with LianMedical, renames company LianMedical

LianBio

LianBio

LIANY

0.00
  • LianBio completed its previously announced merger with LianMedical, with LianBio remaining as the surviving entity.
  • The combined company changed its name to LianMedical upon closing.
  • LianMedical is headquartered in Shanghai, focusing on medical devices for China and Asia-Pacific markets, with initial commercial revenue.
  • Each LianMedical ordinary share was cancelled for 68 ordinary shares of the surviving company, with fractional shares rounded up.
  • The company’s American Depositary Shares continue trading on the OTC Pink under the symbol LIANY.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. LianBio published the original content used to generate this news brief via Business Wire (Ref. ID: 20260716287767) on July 17, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.